Loading...
•
Jun 30, 2022
SI-BONE Q2 2022 Earnings Report
Reported financial results for the second quarter of 2022.
Key Takeaways
SI-BONE, Inc. reported record worldwide revenue of $25.6 million for the second quarter 2022, representing approximately 15% increase over the corresponding period in 2021. The company's gross margin was 86% for the second quarter 2022.
Record worldwide revenue of $25.6 million for the second quarter 2022, representing approximately 15% increase over the corresponding period in 2021
Record U.S. revenue of $23.8 million for the second quarter 2022, representing approximately 18% increase over the corresponding period in 2021
Gross margin of 86% for the second quarter 2022
Received FDA clearance for an expanded indication for iFuse-TORQ® which includes use of the device in pelvic fragility and insufficiency fractures
SI-BONE
SI-BONE
Forward Guidance
The Company continues to expect total 2022 revenue of approximately $106 million to $108 million, representing growth of 18% to 20% compared to full year 2021. The Company continues to expect gross margin to be in the mid-80 percent range for fiscal year 2022.